WebJan 1, 2012 · Background:. Only scarce information is available on the long-term outcome and the natural course of children with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1) due to mutations in the IGHMBP2 gene.Objective:. To describe the natural disease course, to systematically quantify the residual capacities of children with … Webman disease, thus representing an animal model of SMARD1 ( 6). Although how IGHMBP2 reduction/loss leads to selective motor neuron degeneration and to the disease phenotype in rodents and humans is unknown, gene therapy is a potential curative therapeutic strategy because it provides a functi onal gene, thereby addressing the cause of the disease.
About SMARD SmashSMARD
WebDec 1, 2024 · SMARD1 iPSC derived motor neurons were obtained by Simone and coworkers. SMARD1 iPSC derived motor neurons do not present developmental defects, … WebMar 13, 2015 · SMARD1 is a motor neuron disease caused by mutations in IGHMBP2. Because it is due to a single gene defect and has a fatal outcome without any effective … log in aspire
Disease mechanisms in spinal muscular atrophy with respiratory …
WebJul 3, 2014 · Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a motor neuron disease caused by mutations in the IGHMBP2 gene, without a cure. Here, we demonstrate that neural stem cells (NSCs) from human-induced pluripotent stem cells (iPSCs) have therapeutic potential in the context of SMARD1. WebSep 1, 2024 · Spinal Muscular Atrophy with Respiratory Distress Type I (SMARD1) is a neurodegenerative disease defined by respiratory distress, muscle atrophy and sensory … WebNov 22, 2024 · Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an extremely rare type of spinal muscular atrophy (SMA) that results from irreversible … industry print exercise 9-2